Sex steroids and the construction and conservation of the adult skeleton

Endocrine Reviews

Volumn 23, Issue 3, 2002, Pages 279-302

  Riggs, B Lawrence ^a   Khosla, Sundeep ^a   Melton III, L Joseph ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; ESTROGEN; GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

AGING; BONE ATROPHY; BONE DEVELOPMENT; BONE MASS; BONE MATURATION; BONE TURNOVER; CALCIUM HOMEOSTASIS; ESTROGEN METABOLISM; HORMONAL REGULATION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PUBERTY; REVIEW; ANIMAL; BONE; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; SEXUAL DEVELOPMENT;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; GONADAL STEROID HORMONES; HUMANS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; SEX CHARACTERISTICS;

EID: 84967614664     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.23.3.0465     Document Type: Review

References (235)

1. Perspective. How many women have osteoporosis?
2. Prevalence of low femoral bone density in older U.S. adults from NHANES III
3. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
4. Hip fractures in the elderly: A world-wide projection
5. Postmenopausal osteoporosis
6. Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment
7. Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy
8. Increases in immunoreactive parathyroid hormone with age
9. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effect of age and dietary calcium
10. Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age
11. 3 and calcium to prevent hip fractures in elderly women
12. Calcium, dairy products and osteoporosis
13. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
14. Metabolism of estrogens and progestins
15. Disorders of the testis and male reproductive tract
16. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
17. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
18. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats
19. Intracrinology: Role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease
20. The role of local estrogen biosynthesis in males and females
21. Characterization of aromatase and 17β-hydroxysteroid dehydrogenase expression in rat osteoblastic cells
22. Androstenedione metabolism in cultured human osteoblast-like cells
23. Human osteoblast-like cells express aromatase immunoreactivity
24. Aromatase expression of human osteoblast-like cells
25. Steroid sulfatase activity in osteoblast cells
26. 3β-hydroxysteroid dehydrogenase activity in human osteoblast-like cells
27. The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells
28. Osteoblast cells (MG-63 and HOS) have aromatase and 5α-reductase activities
29. Aromatase in human bone tissue
30. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells
31. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
32. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
33. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
34. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation
35. Direct modulation of osteoblastic activity with estrogen
36. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
37. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro
38. Bone dynamics in metabolic bone disease
39. Skeletal heterogeneity and the purposes of bone remodeling: Implications for the understanding of osteoporosis
40. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis
41. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women
42. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens
43. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
44. Gender-independent induction of murine osteoclast apoptosis in vitro by either estrogens or non-aromatizable androgens
45. Androgens directly stimulate proliferation of bone cells in vitro
46. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat
47. Estrogen inhibition of periosteal bone formation in rat long bones: Down-regulation of gene expression for bone matrix proteins
48. Evidence of estrogen receptors in normal human osteoblast-like cells
49. Estrogen binding receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells
50. Avian osteoclasts as estrogen target cells
51. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells
52. Preliminary evidence for impaired estrogen receptor-α protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis
53. The role of estrogen in the control of rat osteocyte apoptosis
54. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
55. Mouse estrogen receptor beta forms estrogen response element binding heterodimers with estrogen receptor-α
56. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
57. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
58. Estrogen receptors α and β are differentially expressed in developing human bone
59. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells
60. Effects of estrogen on growth plate senescence and epiphyseal fusion
61. Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage
62. Identification of androgen receptors in normal human osteoblast-like cells
63. Androgens regulate bone resorption activity of isolated osteoclasts in vitro
64. Estrogen receptor null mice: What have we learned and where will they lead us?
65. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice
66. Disproportional body growth in female estrogen receptor-α-inactivated mice
67. Female estrogen receptor β-/- mice are partially protected against age-related trabecular bone loss
68. The role of estrogen receptor-β (ER-β) in the early age-related bone gain and later age-related bone loss
69. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-β in bone remodeling in females but not in males
70. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
71. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat
72. Bone has a sexually dimorphic response to aromatase deficiency
73. The mechanisms of estrogen regulation of bone resorption
74. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae
75. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone
76. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
77. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
78. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
79. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1- and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
80. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression
81. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
82. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells
83. High-affinity androgen binding and androgenic regulation of cd(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells
84. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line
85. Regulation of c-fos expression and TGF-β production by gonadal and adrenal androgens in normal human osteoblastic cells
86. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor β in rat bone, and reduction is prevented by testosterone
87. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line
88. Regulation of osteoprotegerin gene expression and protein production by androgens and anti-androgens in human osteoblastic cells
89. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men
90. The role of changes in mechanical usage set points in the pathogenesis of osteoporosis
91. On rho, a marrow mediator, and estrogen: Their roles in bone strength and "mass" in human females, osteopenias, and osteoporosis-insights from a new paradigm
92. Perspective: On the estrogen-bone relationship and postmenopausal bone loss
93. Osteocytes, strain detection, bone modeling and remodeling
94. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: Evidence for autonomy from factors released during bone resorption
95. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain
96. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females
97. Mechanical strain activates estrogen response elements in bone cells
98. Mechanical strain and estrogen activate estrogen receptor α in bone cells
99. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls
100. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
101. Volumetric bone mineral density in normal subjects, aged 5-27 years
102. Changes in vertebral bone density in black girls and white girls during childhood and puberty
103. A longitudinal study of bone gain in pubertal girls: Anthropometric and biochemical correlates
104. The differing tempo of growth in bone size, mass, and density in girls is region-specific
105. From density to structure: Growing up and growing old on the surfaces of bone
106. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis
107. Neurobiological mechanisms of the onset of puberty in primates
108. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
109. Estrogen, bone, growth and sex: A sea change in conventional wisdom
110. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
111. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
112. Effect of testosterone and estradiol in a man with aromatase deficiency
113. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
114. Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogen in pubertal growth in girls
115. The contribution of testosterone to skeletal development and maintenance: Lessons from the androgen insensitivity syndrome
116. Structural trends in the aging femoral neck and proximal shaft: Analysis of the third national health and nutrition examination survey dual-energy x-ray absorptiometry data
117. Application of biomechanics to the aging human skeleton
118. Sex steroids and bone mass: A study of changes about the time of menopause
119. Rates of bone loss in the appendicular and axial skeletons of women: Evidence of substantial vertebral bone loss before menopause
120. Determinants of bone loss from the femoral neck in women of different ages
121. Characterization of perimenopausal bone loss: A prospective study
122. A prospective study of bone loss in menopausal Australian-born women
123. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling
124. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study
125. Androstenedione and testosterone in ovarian venous and peripheral plasma during ovariectomy for breast cancer
126. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
127. The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass change
128. Effects of natural and artificial menopause on plasma and urinary calcium and phosphorus
129. 3 in oophorectomized women
130. Estrogen protection against bone resorbing effects of parathyroid hormone infusion
131. Endogenous residual estrogen levels determine bone resorption even in late postmenopausal women
132. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption
133. 2D action
134. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion
135. Evidence for a renal calcium leak in postmenopausal women
136. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption
137. Dietary calcium and hip fracture risk: The NHANES I epidemiologic follow-up study
138. 3
139. Histologic parathyroid abnormalities in an autopsy series
140. The course of bone gain and the phases of bone loss
141. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women
142. Evidence for estrogen receptor-linked calcium transport in the intestine
143. Estrogen regulation of intestinal calcium absorption in the intact ovariectomized adult rat
144. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis
145. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause - A clinical research center study
146. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis
147. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism
148. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone
149. Anabolic actions of parathyroid hormone on bone
150. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation
151. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
152. Insulin-like growth factors I and II, aging and bone density in women
153. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis
154. Concentrations of insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein-4 and -5 in human bone cell conditioned media do not change with age
155. Menopausal changes in bone remodeling
156. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
157. Anabolic effect of estrogen replacement on bone in post-menopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study
158. Does estrogen stimulate osteoblast function in postmenopausal women?
159. Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens
160. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study
161. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate
162. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
163. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
164. On the regulation of sex-hormone-binding globulin - A challenge of an old dogma and outlines of an alternative mechanism
165. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats
166. Femoral bone density and length in male and female estrogen receptor-α (ERα) knockout mice
167. Effects of dihydrotestosterone on bone biochemical markers in sham and oophorectomized rats
168. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-α knockout mice
169. Male osteoporosis predictors: Sex hormones and calcitropic hormones
170. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males
171. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men
172. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study
173. Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study
174. Relationship of sex steroids to longitudinal changes in bone mineral density and bone resorption in young versus elderly men: Effects of estrogen on peak bone mass and on age-related bone loss
175. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men
176. Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: A hypothesis
177. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ-/- mice
178. Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat
179. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: A cross-sectional and longitudinal study
180. Evidence for two distinct syndromes of involutional osteoporosis
181. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
182. Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures
183. Evidence that postmenopausal women with vertebral fractures due to type I osteoporosis have enhanced bone responsiveness to estrogen deficiency
184. Treatment of postmenopausal osteoporosis with transdermal estrogen
185. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures
186. Hormonal predictors of bone loss in elderly women: A prospective study
187. Endogenous hormones and the risk of hip and vertebral fractures among older women
188. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women
189. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion
190. Altered hydroxylation of estrogen in patients with postmenopausal osteopenia
191. Comment on altered hydroxylation of estrogen in patients with postmenopausal osteopenia
192. Nuclear receptor co-regulators: Cellular and molecular biology
193. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
194. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not
195. Association of bone mineral density with polymorphism of the estrogen receptor gene
196. Estrogen receptor α gene polymorphisms and bone mineral density: Haplotype analysis in women from the United Kingdom
197. Early post-menopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy
198. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density
199. No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women
200. Genetic control of bone density and turnover: Role of the collagen 1 α-1, estrogen receptor, and vitamin D receptor genes
201. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality
202. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis
203. Polymorphism of the aromatase gene in postmenopausal Italian women: Distribution and correlation with bone mass and fracture risk
204. Genetics of male osteoporosis
205. On our age-related bone loss: Insights from a new paradigm
206. Why the ISMNI and the Utah paradigm? Their role in skeletal and extraskeletal disorders
207. Relative influence of physical activity, muscle mass and strength on bone density
208. Prevention of spinal osteoporosis in oophorectomised women
209. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy
210. Three-year follow-up on effects of transdermal estrogen
211. Exercise: Moving in the right direction
212. Bone mineral content of amenorrheic and eumenorrheic athletes
213. The two faces of growth: Benefits and risks to bone integrity
214. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
215. Vitamin D and osteoporosis
216. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial
217. Impaired vitamin D metabolism with aging in women: Possible role in pathogenesis of senile osteoporosis
218. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly
219. Changes with aging of steroidal levels in the cerebrospinal fluid of women
220. The contribution of bone loss to postmenopausal osteoporosis
221. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 Year study
222. Models of spinal trabecular bone loss as determined by quantitative computed tomography
223. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: Insights from the daughters of women with vertebral or hip fractures
224. Determinants of peak bone mass and mechanisms of bone loss
225. Genetic epidemiological approaches to the search for osteoporosis genes
226. Medical progress series: Involutional osteoporosis
227. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause
228. Osteoporosis in women with anorexia nervosa
229. Does calcium supplementation prevent postmenopausal bone loss: A double-blind, controlled clinical study
230. Reproduction in the female and egg production
231. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions